Re-modulation of the tumor microenvironment by low-dose DAC in CT26-bearing mice. a The mice were inoculated with the tumor, and beginning 7 days later, each mouse received peritoneal injections of 20 μg of DAC for 5 consecutive days. The last day of injection was recorded as DAC-0 day. The mice were sacrificed at DAC-1, DAC-3, DAC-7 and DAC-14 days. The tumor sections were stained for CD3 by IHC. b The stained slides were analyzed using the PerkinElmer Vectra 3 automated, high-throughput quantitative pathology imaging system. CD3-positive T cells were counted under ×200 magnification. From each slide, ten fields were selected for analysis. The results were analyzed using ANOVA. *p < 0.05, ***p < 0.001, ns indicates no significant difference. c The tumors on DAC-7 day from the PBS-treated, cytidine-treated and DAC-treated mice were stained for CD3, CD4, CD8, IFN-γ and PD-1. d The stained slides were analyzed using the PerkinElmer Vectra 3 automated, high-throughput quantitative pathology imaging system. The positive cells were counted under ×200 magnification. From each slide, ten fields were selected for analysis. The results were analyzed using ANOVA. ***p < 0.001.
